Quantamatrix - About the company
Quantamatrix is a public company based in Seoul (South Korea), founded in 2010 by Sunghoon Kwon. It operates as a Multiplexed platform for disease daignosis. Quantamatrix has raised $198K in funding from Treatment Action Group. The company has 340 active competitors, including 80 funded and 50 that have exited. Its top competitors include companies like Adaptive Biotechnologies, MeMed and HaystackAnalytics.
Company Details
QuantaMatrix is focused on development and commercialization of molecular and cellular diagnostic tools and related disposable kits. The company has developed an immunodiagnostic platform based on their proprietary encoded microdisk technology. The company claims that 1000 multiplex are possible in 1 microwell. The company offers microfluidic chips and automated imaging systems, a direct Rapid Antibiotic Susceptibility Test is a fully automated microscopic imaging tool (4 hours). The available diagnostic tests include an HPV kit and an STD kit for pathogen detection.
- Website
- quantamatrix.com
- Email ID
- *****@quantamatrix.com
Key Metrics
Founded Year
2010
Location
Seoul, South Korea
Stage
Public
Total Funding
$198K in 1 round
Latest Funding Round
Investors
Ranked
9th among 340 active competitors
Employee Count
72 as on May 31, 2026
Similar Companies
Exit Details
Public
Quantamatrix's IPO details
Quantamatrix got listed on Dec 09, 2020.
Click here to take a look at Quantamatrix's IPO in detail
Sign up to download Quantamatrix's company profile
Quantamatrix's funding and investors
Quantamatrix has raised a total funding of $198K over 1 round. Its latest funding round was a Seed round on 2014 for $*****. 1 investor participated in its latest round. Quantamatrix has 8 institutional investors.
Here is the list of recent funding rounds of Quantamatrix:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
2014 | 7791 | Seed | 6249 | 7025 | 1942 | 2271 |
View details of Quantamatrix's funding rounds and investors
Quantamatrix's founders and board of directors
Founder? Claim ProfileThe founders of Quantamatrix is Sunghoon Kwon. Sunghoon Kwon is the CEO of Quantamatrix.
Here are the details of Quantamatrix's key team members:
- Sunghoon Kwon: Founder & CEO of Quantamatrix. Contact Info: 1 email address
View details of Quantamatrix's Founder profiles and Board Members
Quantamatrix's employee count trend
Quantamatrix has 72 employees as of May 26. Here is Quantamatrix's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Quantamatrix's Competitors and alternates
Top competitors of Quantamatrix include Adaptive Biotechnologies, MeMed and HaystackAnalytics. Here is the list of Top 10 competitors of Quantamatrix, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Adaptive Biotechnologies 2009, Seattle (United States), Public | Provider of clinical diagnostics, and drug discovery for immune diseases | $419M | 77/100 | |
2nd | Provider of machine learning based diagnostic solutions for infectious diseases | $163M | 69/100 | ||
3rd | HaystackAnalytics 2018, Mumbai (India), Seed | Provider of genomics technology for personalized clinical decisions | $17.3M | 67/100 | |
4th | Inflammatix 2016, San Francisco (United States), Series E | Provider of diagnostic solutions for systemic infections | $191M | 64/100 | |
5th | Seegene Technologies 2000, Seoul (South Korea), Public | Developer of molecular diagnostic kits to detect infectious and genetic diseases | - | 59/100 | |
6th | Oncimmune 2006, Cambridge (United States), Acquired | Immunodiagnostics company developing biomarker platforms for cancer and immune diseases | - | 58/100 | |
7th | Karius 2014, Redwood City (United States), Series C | Provider of diagnostics for identifying infectious diseases using microbial DNA | $315M | 58/100 | |
8th | Clear Labs 2014, Menlo Park (United States), Series D | Provider of food safety technologies for the identification of pathogens | $171M | 57/100 | |
9th | Quantamatrix 2010, Seoul (South Korea), Public | Multiplexed platform for disease daignosis | $198K | 55/100 | |
10th | T2 Biosystems 2006, Lexington (United States), Public | Developer of miniaturized MRI platforms for clinical diagnostics | $454M | 55/100 |
Looking for more details on Quantamatrix's competitors? Click here to see the top ones
Quantamatrix's Investments and acquisitions
Quantamatrix has made no investments or acquisitions yet.
News related to Quantamatrix
Media has covered Quantamatrix for 1 event in last 1 year, It was about company updates.
•
•
AMR testing technology from QuantaMatrix backed by research paper in NaturePharmaTimes•Aug 21, 2024•Quantamatrix
•
QuantaMatrix Develops “the World’s Fastest” All-in-One Antimicrobial Testing TechnologyEuropean Pharmaceutical Manufacturer•Aug 20, 2024•Quantamatrix
•
Quanta Matrix ‘dRAST’ selected as next-generation world-class productVenture Square•Nov 10, 2023•Quantamatrix
•
Cultivating a Partnership with QuantaMatrix for Sepsis Diagnosis “dRAST” in Southeast AsiaBiomed Global•Sep 11, 2023•Biomed Global, Quantamatrix
•
Limbach Group adopts QuantaMatrix dRAST™ in routine clinical usePR Newswire•Dec 15, 2021•, Quantamatrix
•
Are you a Founder ?
FAQs about Quantamatrix
Explore our recently published companies
- Trufactor.com - 2004 founded, Unfunded company
- Kolo - India based, Unfunded company
- LeadQC - 2026 founded, Unfunded company
- Eulogewfinancial - 2016 founded, Unfunded company
- Maemos - 2007 founded, Unfunded company
- Affinitytreatments - Unfunded company